Hermetica Superfood Encyclopedia
The Short Answer
Cucurbitacin E is a triterpenoid compound found in cucurbitaceae plants that exhibits potential anticancer properties through cell cycle disruption and apoptosis induction. Preliminary research suggests it may modulate immune responses and cellular survival pathways, though human clinical evidence is lacking.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordcucurbitacin E benefits
Synergy Pairings3

Cucurbitacin E (Triterpenoid) — botanical close-up
Health Benefits
Origin & History

Natural habitat
Cucurbitacin E is a natural tetracyclic triterpenoid (C32H44O8) found primarily in plants of the Cucurbitaceae family, including Luffa cylindrica, cucumbers, muskmelons, and watermelons, where it contributes to their bitter taste. This compound is isolated from these plant sources for research purposes, though specific extraction methods are not detailed in current literature.
“Cucurbitacin E is found in traditional Chinese medicinal plants from the Cucurbitaceae family, though specific historical uses for this isolated compound are not documented. The broader class of cucurbitacins has been noted for pro-survival activities linked to their presence in Cucurbit plants.”Traditional Medicine
Scientific Research
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on Cucurbitacin E. All available research is limited to preclinical studies examining potential anticancer and immunomodulatory effects in cellular models, with no PMIDs provided in the research dossier.
Preparation & Dosage

Traditional preparation
No clinically studied dosage ranges are available for Cucurbitacin E as human trials have not been conducted. The compound has low water solubility and is classified as harmful if swallowed (H302 acute oral toxicity). Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Cucurbitacin E is a highly oxygenated tetracyclic triterpenoid belonging to the cucurbitacin family, naturally occurring in plants of the Cucurbitaceae family (e.g., cucumbers, gourds, melons) as well as some other plant genera. It is characterized by a cucurbitane carbon skeleton with multiple hydroxyl and carbonyl functional groups, contributing to its potent and bitter-tasting bioactive properties. As a secondary plant metabolite rather than a conventional nutrient, it is present in trace amounts in edible cucurbits and has no established dietary reference intake.
How It Works
Mechanism of Action
Cucurbitacin E appears to disrupt cellular microtubules and interfere with cell cycle progression, particularly affecting the G2/M checkpoint. The compound may modulate various signaling pathways including JAK/STAT, NF-κB, and PI3K/Akt pathways, leading to altered gene expression and cellular responses. Its immunomodulatory effects likely involve cytokine regulation, though specific receptor interactions remain unclear.
Clinical Evidence
Current evidence for cucurbitacin E is limited to preclinical in vitro and animal studies, with no published human clinical trials available. Laboratory studies have demonstrated anticancer activity against various cancer cell lines, showing growth inhibition and apoptosis induction at micromolar concentrations. Animal studies suggest potential anti-inflammatory and hepatoprotective effects, but these findings have not been validated in human populations. The lack of clinical data makes it impossible to establish therapeutic efficacy or optimal dosing in humans.
Safety & Interactions
Safety data for cucurbitacin E in humans is extremely limited due to the absence of clinical trials. Cucurbitacins as a class can be toxic at high doses, potentially causing gastrointestinal irritation, hepatotoxicity, and cellular damage. No specific drug interactions have been documented, but theoretical concerns exist regarding interactions with chemotherapy agents or immunosuppressive medications. Pregnant and breastfeeding women should avoid cucurbitacin E due to insufficient safety data and potential teratogenic effects.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cucurbitacin-ECuE23,24-Dihydrocucurbitacin DTetracyclic triterpenoid cucurbitacin EC32H44O8 cucurbitacinLuffa cylindrica cucurbitacin EBitter principle cucurbitacin E
Frequently Asked Questions
What foods contain cucurbitacin E naturally?
Cucurbitacin E is found in various members of the cucurbitaceae family, including bitter melons, wild gourds, and some cucumber varieties. The highest concentrations typically occur in the stems, leaves, and roots rather than the edible fruits.
How much cucurbitacin E should I take daily?
There is no established safe or effective dosage for cucurbitacin E supplements in humans. Preclinical studies used concentrations ranging from 1-50 μM in cell cultures, but these cannot be extrapolated to human dosing without clinical trials.
Can cucurbitacin E help with cancer treatment?
While laboratory studies show promising anticancer activity against various cancer cell lines, there is no human clinical evidence supporting cucurbitacin E as a cancer treatment. It should never be used as a substitute for proven cancer therapies.
Does cucurbitacin E have side effects?
Potential side effects are unknown due to lack of human studies, but cucurbitacins can be toxic at high doses, potentially causing liver damage and gastrointestinal issues. Professional medical supervision would be essential for any therapeutic use.
Is cucurbitacin E the same as other cucurbitacins?
Cucurbitacin E is one specific member of the cucurbitacin family of triterpenoids, which includes cucurbitacins A, B, D, and others. While they share structural similarities, each has distinct biological activities and potencies.
What does the current clinical evidence say about cucurbitacin E's effectiveness in humans?
Currently, there are no published human clinical trials testing cucurbitacin E directly, so its effectiveness in people remains unproven. All existing evidence comes from laboratory cell studies and animal models, which show preliminary promise but cannot be directly applied to human health outcomes. Clinical research is needed before any health claims can be substantiated for human use.
Does cucurbitacin E interact with common medications?
Limited information exists on potential drug interactions with cucurbitacin E in humans due to the lack of clinical studies. Because cucurbitacin E may modulate immune function based on preliminary research, there is theoretical concern for interactions with immunosuppressant medications, though this has not been formally studied. Consult a healthcare provider before combining cucurbitacin E supplements with prescription medications.
Is cucurbitacin E safe during pregnancy or for young children?
Safety data for cucurbitacin E in pregnant women, nursing mothers, and children is not available from clinical studies. Some cucurbitacins are known to have toxic effects at high concentrations in animal studies, raising caution about use in vulnerable populations. Pregnant women, nursing mothers, and young children should avoid cucurbitacin E supplements unless explicitly approved by a healthcare provider.

Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cucurbitacin-e curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)